Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome

Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial

The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.

The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery

Participants will randomized to receive the study intervention or standard of care.

Inclusion Criteria:

• Adults 18-89 years of age
• Required admission to either medical or surgical ICU
• Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
• Anticipated discharge to home after hospitalization
• Consent from patients themselves or a legally authorized representative if necessary

Exclusion Criteria:

• Pregnancy
• Incarceration/Imprisonment
• Life expectancy less than 6 months or enrolled in hospice/palliative care
• Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
• Unable to participate in telehealth